Design and preparation of gadolinium-loaded chitosan particles for cancer neutron capture therapy

S.T.P. Pharma Sciences

Volumn 10, Issue 1, 2000, Pages 39-49

  Tokumitsu, H ^a   Ichikawa, H ^a   Saha, T K ^a   Fukumori, Y ^a   Block, L H ^b  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b DUQUESNE UNIVERSITY   (United States)

Author keywords

Chitosan; Coalescence; Cross linking agent; Emulsion; Gadolinium; Gadopentetic acid; Microparticle; Microsphere; Nanoparticle; Neutron capture therapy

Indexed keywords

CHITOSAN; GADOLINIUM;

CANCER INHIBITION; CANCER THERAPY; DRUG DESIGN; EMULSION; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PARTICLE SIZE; REVIEW; SOLUBILITY; TUMOR VOLUME;

EID: 0034003037     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. BARTH R.F. and SOLOWAY A.H. - Boron neutron capture therapy of primary and metastatic brain tumors. - Mol. Chem. Neuropathol., 21, 139-154, 1994.
2. BARTH R.F., SOLOWAY A.H. and FAIRCHILD R.G. - Boron neutron capture therapy of cancer. - Cancer Res., 50, 1061-1070, 1990.
3. HATANAKA H. - Boron neutron capture therapy for tumors - In: Boron Neutron Capture Therapy for Tumors, H. Hatanaka Ed., Nishimura, Niigata, 1986, pp. 1-28.
4. 10B molecule-melanoma cell interaction from in vitro to first clinical trial. - Pigment Cell Res., 2, 226-234, 1989.
5. 157Gd. - Nucl. Phys., A304, 327-428, 1978.
6. BRUGGER R.M. and SHIH J.A. - Evaluation of gadolinium-157 as a neutron capture therapy agent. - Strahlenther. Onkol., 165, 153-156, 1989.
7. ALLEN B.J., MCGREGOR B.J. and MARTIN R.F. - Neutron capture therapy with gadolinium-157. - Strahlenther. Onkol., 165, 156-157, 1989.
8. GARBER D.I. and KINSEY, R.R. - In : Neutron Cross Sections Report, BNL-325, 3rd ed., Brookhaven National Laboratory, New York, 1976.
9. SHIH J.A. and BRUGGER R. - Gadolinium as a neutron capture therapy agent. - Med. Phys., 19, 733-744, 1992.
10. 157Gd. - Int. J. Radiat. Biol., 54, 205-208, 1988.
11. HOFMANN B., FISCHER C.-O., LAWACZECK R., PLATZEK J. and SEMMLER W. - Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol. - Invest. Radiol., 34, 126-133, 1999.
12. KHOKHLOV V.F., YASHKIN P.N., SILIN D. I., DJOROVA E. S. and LAWACZECK R. - Neutron capture therapy with Gd-DTPA in tumor-bearing rats. - In : Cancer Neutron Capture Therapy, Y. Mishima Ed., Plenum Press, New York, 1996, pp. 865-869.
13. LAWACZECK R., FISCHER C.-O., KRÜGER U., LEUTHER W. and MENRAD J. - Gadolinium neutron capture therapy (GdNCT) with MRI contrast media. In vitro study. - In: Cancer Neutron Capture Therapy, Y. Mishima Ed., Plenum Press, New York, 1996, pp. 859-864.
14. AKINE Y., TOKITA N., TOKUUYE K., SATOH M., CHUREI H., PECHOUX C.L., KOBAYASHI T. and KANDA K. - Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy. - Jpn. J. Cancer Res., 84, 841-843, 1993.
15. AKINE Y., TOKITA N., TOKUUYE K., SATOH M., KOBAYASHI T. and KANDA K. - Electron-equivalent dose for the effect of gadolinium neutron capture therapy on the growth of subcutaneously-inoculated Ehrlich tumor cells in mice. - Jpn. J. Clin. Oncol., 23, 145-148, 1993.
16. AKINE Y., TOKITA N., MATSUMOTO T., OYAMA H., EGAWA S. and AIZAWA O. - Radiation effect of gadolinium-neutron capture reactions on survival of Chinese hamster cells. - Strahlenther. Onkol., 166, 831-833, 1990.
17. TAKAGAKI M., ODA Y., MIYATAKE S., KIKUCHI H., KOBAYASHI T., KANDA K. and UJENO Y. - Killing effects of gadolinium neutron capture reactions on brain tumors. - In: Progress in Neutron Capture Therapy for Cancer, B. J. Allen et al. Eds., Plenum Press, New York, 1992, pp. 407-410.
18. MATSUMOTO T. - Transport calculations of depth-dose distributions for gadolinium neutron capture therapy. - Phys. Med. Biol., 37, 155-162, 1992.
19. FUKUMORI Y., ICHIKAWA H., TOKUMITSU H., MIYAMOTO Y., JONO K., KANAMORI R., AKINE Y. and TOKITA N. - Design and preparation of ethyl cellulose microcapsules of gadopentetate dimeglumine for neutron-capture therapy using the Wurster process. - Chem. Pharm. Bull., 41, 1144-1148, 1993.
20. AKINE Y., TOKITA N., TOKUUYE K., SATOH M., FUKUMORI Y., TOKUMITSU H., KANAMORI R., KOBAYASHI T. and KANDA K. - Neutron-capture therapy of murine ascites tumor with gadolinium-containing microcapsules. - J. Cancer Res. Clin. Oncol., 119, 71-73, 1992.
21. KAWASHIMA Y., YAMAMOTO H., TAKEUCHI H., HINO T. and NIWAT. - Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. - Eur. J. Pharm. Biopharm., 45, 41-48, 1998.
22. LÖBENBERG R., ARAUJO L., VON BRIESEN H., RODGERS E. and KREUTER J. - Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after IV injection to rats. - J. Control. Release, 50, 21-30, 1998.
23. VANDORPE J., SCHACHT E., DUNN S., HAWLEY A., STOLNIK S., DAVIS S.S., GARNETT M.C., DAVIES M.C. and ILLUM L. - Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer. - Biomaterials, 18, 1147-1152, 1997.
24. MÜLLER R.H., MAASSEN S., SCHWARZ C. and MEHNERT W. - Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. - J. Control.Release, 47, 261-269, 1997.
25. SONG C.X., LABHASETWAR V., MURPHY H., QU X., HUMPHREY W.R., SHEBUSKI R.J. and LEVY R.J. - Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. - J. Control. Release, 43, 197-212, 1997.
26. LEROUX J.-C., ALLÉMANN E., DEJAEGHERE F., DOELKER E. and GURNY R. - Biodegradable nanoparticles from sustained release formulations to improved site specific drug delivery. - J. Control. Release, 39, 339-350, 1996.
27. MÜLLER B.G., LEUENBERGER H. and KISSEL T. - Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. - Pharm. Res., 13, 32-37, 1996.
28. CALVO P., SÁNCHEZ A., MARTÍNEZ J., LÓPEZ M.I., CALONGE M., PASTOR J.C. and ALOMSO M.J. - Polyester nanoparticles as new topical ocular delivery systems for cyclosporin A. - Pharm. Res., 13, 311-315, 1996.
29. MASSON V., MAURIN F., DEVISSAGUET J.P. and FESSI H. - Stability of poly (ε caprolacton) nanospheres in sterile aqueous media. - Int. J. Pharm., 139, 113-123, 1996.
30. NAKADA Y., FATTAL E., FOULQUIER M. and COUVREUR P. - Pharmacokinetics and Biodistribution of Oligonucleotide absorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. - Pharm. Res., 13, 38-43, 1996.
31. BAZILE D., PRUD'HOMME C., BASSOULLET M.-T., MARLARD M., SPENLEHAUER G. and VEILLARD M. - Stealth Me. PEGPLA nanoparticles avoid uptake by the mononuclear phagocytes system - J. Pharm. Sci., 84, 493-498, 1995.
32. VERRECCHIA T., SPENLEHAUER G., BAZILE D. V., MURRYBRELIER A., ARCHIMBAUD Y. and VEILLARD M. - Nonstealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. - J. Control. Release, 36, 49-61, 1995.
33. GREF R., MINAMITAKE Y., PERACCHIA M.T., TRUBETSKOY V., TORCHILIN V. and LANGER R. - Biodegradable long-circulating polymeric nanospheres. - Science, 263, 1600-1603, 1994.
34. AMMOURY N., FESSI H., DEVISSAGUET J.P., PUISIEUX F. and BENITA S. - In vitro release kinetic pattern of indomethacin from poly (D,L-lactide) nanocapsules. - J. Pharm. Sci., 79, 763-767, 1990.
35. FELT O., BURI P. and GURNY R. - Chitosan: a unique polysaccharide for drug delivery. - Drug Dev. Ind. Pharm., 24, 979-993, 1998.
36. CALVO P., REMUÑAN-LÓPEZ C., VILA-JATO J.L. and ALONSO M.J. - Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. - Pharm. Res., 14, 1431-1436, 1997.
37. BERTHOLD A., CREMER K. and KREUTER J. - Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. - J. Control. Release, 39, 17-25, 1996.
38. MUZZARELLI R., BALDASARRE V., CONTI F., FERRARA P., BIAGINI G., GAZZANELLI G. and VASI V. - Biological activity of chitosan: ultrastructural study. - Biomaterials, 9, 247-252, 1988.
39. HIRANO S., SEINO H., AKIYAMA Y. and NONAKA I. - Biocompatibility of chitosan by oral and intravenous administration. - Polym. Eng. Sci., 59, 897-901, 1988.
40. ARAI K., KINUMAKI T. and FUJITA T. - Toxicity of chitosan. -Bull. Tokai Reg. Fish Lab., 43, 89-94, 1968.
41. LEHR C.-M., BOUWSTRA J.A., SCHACHT E.H. and JUNGINGER H.E. - In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymer. - Int. J. Pharm., 78, 43-48, 1992.
42. LEE K.Y., HA W.S., and PARK W.H. - Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. -Biomaterials, 16, 1211-1216, 1995.
43. SHIGEMASA Y., SAITO K., SASHIWA H. and SAIMOTO H. -Enzymatic degradation of chitins and partially deacetylated chitins. - Int. J. Biol. Macromol., 16, 43-49, 1993.
44. HIRANO S., TSUCHIDA H. and NAGAO N. - N-acetylation in chitosan and the rate of its enzymic hydrolysis. - Biomaterials, 10, 574-576, 1989.
45. PANGBURN S.H., TRESCONY P.V. and HELLER J. - Lysozyme degradation of partially deacetylated chitin, its films and hydrogels. - Biomaterials, 3, 105-108, 1982.
46. ARTURSSON P., LINDMARK T., DAVIS S.S. and ILLUM L. -Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). - Pharm. Res., 11, 1358-1361, 1994.
47. WEINMANN H.-J., BRASCH R.C., PRESS W.-R. and WESBEY G.E. - Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. - Am. J. Rad., 142, 619-624, 1984.
48. GOLDSTEIN H.A., KASHANIAN F.K., BLUMETTI R.F., HOLYOAK W.L., HUGO P.P. and BLUMENFIELD D.M. - Safety assessment of gadopentetate dimeglumine in U.S. clinical trials. - Radiology, 174, 17-23, 1990.
49. NISHIOKA Y., KYOTANI S., OKAMURA M., MIYAZAKI M., OKAZAKI K., OHNISHI S., YAMAMOTO Y. and ITO K. -Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. - Chem. Pharm. Bull., 38, 2871-2873, 1990.
50. OHYA Y., TAKEI T., KOBAYASHI H. and OUCHI T. - Release behavior of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. - J. Microencapsulation, 10, 1-9, 1993.
51. AKBUGA J. and DURMAZ G. - Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. -Int. J. Pharm., 111, 217-222, 1994.
52. HASSAN E.E., PARISH R.C. and GALLO J.M. - Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. - Pharm. Res., 9, 390-397, 1992.
53. THANOO B.C., SUNNY M.C. and JAYAKRISHNAN A. - Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. - J. Pharm. Pharmacol., 44, 283-286, 1992.
54. JAMEELA S.R. and JAYAKRISHNAN A. - Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and vivo degradation of microspheres in rat muscle. - Biomaterials, 16, 769-775, 1995.
55. SAHA T.K., JONO K., ICHIKAWA H. and FUKUMORI Y. -Preparation and evaluation of glutaraldehyde cross-linked chitosan microspheres as a gadolinium reservoir for neutron-capture therapy. - Chem. Pharm. Bull., 46, 537-539, 1998.
56. LONGO W.E., IWATA H., LINDHEIMER T.A. and GOLDBERG E.P. - Preparation of hydrophilic albumin microspheres using polymeric dispersing agent. - J. Pharm. Sci., 71, 1323-1328, 1982.
57. LATHA M.S., RATHINAM K., MOHANAN P.V. and JAYAKRISHNAN A. - Bioavailability of theophylline from glutaraldehyde cross-linked casein microspheres in rabbits following oral administration. - J. Controlled Release, 34, 1-7, 1995.
58. TOKUMITSU H., ICHIKAWA H., FUKUMORI Y. and BLOCK L.H. - Preparation of gadopentetate-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. - Chem. Pharm. Bull., 47, 838-842, 1999.
59. TOKUMITSU H., ICHIKAWA H. and FUKUMORI Y. - Chitosan-gadopentetic acid complex nanoparticlesforgadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. - Pharm. Res., 16, 1830-1835, 1999.
60. KOBAYASHI T. and KANDA K. - Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry. - Nucl. Instrum. Methods, 204, 525-531, 1983.
61. HONDA C., MISHIMA Y., ICHIHASHI M. and HATTA S. - In-situ detection of cutaneous melanoma-seeking 10B-dopa analogue. - J. Dermatol. Sci., 1, 23-32, 1990.
62. BURGER J.J., TOMLINSON E., MULDER E.M.A. and MCVIE J.G. - Albumin microspheres for intra-arterial tumor targeting. I. Pharmaceutical aspects. - Int. J. Pharm., 23, 333-344, 1985.
63. ICHIHASHI M., SASASE A., HIRAMOTO T., FUNASAKA Y., HATTA S., MISHIMA Y., KOBAYASHI T., FUKUDA H. and YOSHINO K. - Relative biological effectiveness (RBE) of thermal neutron capture therapy of cultured B-16 melanoma cells pre-incubated with 10B-paraboronophenylalanine. - Pigment Cell Res., 2, 325-329, 1989.
64. TOKUMITSU H., HIRATSUKA J., SAKURAI Y., KOBAYASHI T., ICHIKAWA H. and FUKUMORI Y. - Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor - Cancer Lett., in press.
65. HIRATSUKA J., FUKUDA H., KOBAYASHI T., KARASHIMA H., YOSHINO K., IMAJO Y. and MISHIMA Y. - The relative biological effectiveness of 10B-neutron capture therapy for early skin reaction in the hamster. - Radiat. Res., 128, 186-191, 1991.
66. KOBAYASHI T., KANDA K., FUJITA Y., SAKURAI Y. and ONO K. - The upgrade of the heavy water facility of the Kyoto University Reactor for neutron capture therapy. - In : Advances in Neutron Capture Therapy Vol. I, B. Larsson et al. Eds., Elsevier Science, Amsterdam, 1997, pp. 321-325.